testosterone 16 16 17 d3 (steraloids inc)
96
Structured Review
steraloids inc
testosterone 16 16 17 d3
Testosterone 16 16 17 D3, supplied by steraloids inc, used in various techniques. Bioz Stars score: 96/100, based on 1017 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/testosterone+16+16+17+d3/4-ANDROSTEN-17%CE%B2-OL-3-ONE/pm19442514-57-3-18
Average 96 stars, based on 1017 article reviews
Testosterone 16 16 17 D3, supplied by steraloids inc, used in various techniques. Bioz Stars score: 96/100, based on 1017 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/testosterone+16+16+17+d3/4-ANDROSTEN-17%CE%B2-OL-3-ONE/pm19442514-57-3-18
Average 96 stars, based on 1017 article reviews
testosterone 16 16 17 d3 - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Mass Spectrometry:Article Title: Steroidogenesis inhibitors alter but do not eliminate androgen synthesis mechanisms during progression to castration-resistance in LNCaP prostate xenografts. Article Snippet: In castration-resistant prostate cancer (CRPC) many androgen-regulated genes become re-expressed and tissue androgen levels increase despite low serum levels.. We and others have recently reported that CRPC tumor cells can de novo synthesize androgens from adrenal steroid precursors or cholesterol and that high levels of progesterone exist in LNCaP tumors after castration serving perhaps as an intermediate in androgen synthesis.. Herein, we compare androgen synthesis from [3H-progesterone] in the presence of specific steroidogenesis inhibitors and anti-androgens in steroid starved LNCaP cells and CRPC tumors. In Vitro:Article Title: Steroidogenesis inhibitors alter but do not eliminate androgen synthesis mechanisms during progression to castration-resistance in LNCaP prostate xenografts. Article Snippet: In castration-resistant prostate cancer (CRPC) many androgen-regulated genes become re-expressed and tissue androgen levels increase despite low serum levels.. We and others have recently reported that CRPC tumor cells can de novo synthesize androgens from adrenal steroid precursors or cholesterol and that high levels of progesterone exist in LNCaP tumors after castration serving perhaps as an intermediate in androgen synthesis.. Herein, we compare androgen synthesis from [3H-progesterone] in the presence of specific steroidogenesis inhibitors and anti-androgens in steroid starved LNCaP cells and CRPC tumors. |